Search - tctmd.com

Displaying 81 - 100 of 1648

Sort: Relevancy | Date

Presentation TCT 2016

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFpEF

Presenter: Bernard J. Gersh, Valluvan Jeevanandam, JoAnn Lindenfeld, Peter Carson

October 31, 2016

Presentation TCT 2016

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFrEF

Presenter: Bernard J. Gersh, Valluvan Jeevanandam, JoAnn Lindenfeld, Ileana L. Pina

October 31, 2016

Presentation TCT 2016

Acute Cardiogenic Shock Treatment Algorithm 3: The Case for First-line Use of ECMO

Presenter: Simon R. Dixon, Holger Thiele, A. Reshad Garan

October 31, 2016

Presentation TCT 2016

Acute Cardiogenic Shock Treatment Algorithm 2: The Case for First-line Use of Impella

Presenter: Simon R. Dixon, Holger Thiele, Jerry D Estep

October 31, 2016

Presentation TCT 2016

Acute Cardiogenic Shock Treatment Algorithm 1: The Case for First-line Use of IABP

Presenter: Simon R. Dixon, Holger Thiele, Susan M Joseph

October 31, 2016

Presentation TCT 2016

Acute Cardiogenic Shock: Pathophysiology and Representative Case Presentation

Presenter: Simon R. Dixon, Holger Thiele, Ulrich P. Jorde

October 31, 2016

News Industry News

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

October 31, 2016

Presentation TCT 2016

TCT 77: Association of Residual Mitral Regurgitation After Transcatheter Aortic Valve Replacement With Readmission for Acute Heart Failure: An Analysis From PARTNER 1

Presenter: John M. Lasala, Philippe Pibarot, John Petersen

October 31, 2016

News Industry News

First-In-Human Of New Polymer-Free Stent Demonstrates Favorable Angiographic And Imaging-Based Outcomes At Nine-Months

October 31, 2016

News Conference News TCT 2016

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Todd Neale

October 31, 2016

News Industry News

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

October 31, 2016

Presentation TCT 2016

TCT 627: Cardiovascular Outcomes Assessment of MitraClip Therapy in Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial): Baseline Characteristics and Preliminary 30-Day and 1-Year Outcomes of the Roll-In Cohort

Presenter: Brij Maini, James E. Muller

October 31, 2016

News Conference News TCT 2016

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Michael O'Riordan

October 31, 2016

News Conference News TCT 2016

Are Full, Formal Guidelines Still Useful in the Rapidly Changing TAVR Field?

Todd Neale

October 30, 2016

Presentation TCT 2016

What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? Stop Wasting Valuable Time Go Straight to LVAD/Transplant!

Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Nir Uriel

October 30, 2016

Presentation TCT 2016

What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? MitraClip Should Always Be Considered First!

Presenter: Alec S. Vahanian, Ralph Stephan von Bardeleben, Saibal Kar

October 30, 2016

Presentation TCT 2016

Beyond Hypertension: Autonomic Modulation Therapies for Chronic Heart Failure

Presenter: Elazer R. Edelman, Krishna J. Rocha-Singh, Farrell O. Mendelsohn

October 30, 2016

Presentation TCT 2016

Moderate Aortic Stenosis + Heart Failure: Introduction to the UNLOAD Trial

Presenter: A. Pieter Kappetein, Allan Schwartz, Martin B. Leon

October 30, 2016

Presentation TCT 2016

Future Therapy for Symptomatic HCM Patients With and Without Dynamic Obstruction

Presenter: George S. Hanzel, Antoine Lafont, Michael A. Fifer

October 30, 2016

Presentation TCT 2016

Debate: Surgery, Septal Ablation or New Medical Therapy for Obstructive HCM - Septal Ablation Is As Good As Surgery and Less Invasive!

Presenter: George S. Hanzel, Antoine Lafont, Carey D. Kimmelstiel

October 30, 2016

Advertisement

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFpEF

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFrEF

Acute Cardiogenic Shock Treatment Algorithm 3: The Case for First-line Use of ECMO

Acute Cardiogenic Shock Treatment Algorithm 2: The Case for First-line Use of Impella

Acute Cardiogenic Shock Treatment Algorithm 1: The Case for First-line Use of IABP

Acute Cardiogenic Shock: Pathophysiology and Representative Case Presentation

TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies

TCT 77: Association of Residual Mitral Regurgitation After Transcatheter Aortic Valve Replacement With Readmission for Acute Heart Failure: An Analysis From PARTNER 1

First-In-Human Of New Polymer-Free Stent Demonstrates Favorable Angiographic And Imaging-Based Outcomes At Nine-Months

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Trial Results Suggest That Drug-Eluting Stents Are Acceptable Alternative To Open Heart Surgery For Select Patients With Left Main Coronary Artery Disease

TCT 627: Cardiovascular Outcomes Assessment of MitraClip Therapy in Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial): Baseline Characteristics and Preliminary 30-Day and 1-Year Outcomes of the Roll-In Cohort

EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease

Are Full, Formal Guidelines Still Useful in the Rapidly Changing TAVR Field?

What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? Stop Wasting Valuable Time Go Straight to LVAD/Transplant!

What Is the Best Treatment for the End-stage Heart Failure Patient With Severe FMR? MitraClip Should Always Be Considered First!

Beyond Hypertension: Autonomic Modulation Therapies for Chronic Heart Failure

Moderate Aortic Stenosis + Heart Failure: Introduction to the UNLOAD Trial

Future Therapy for Symptomatic HCM Patients With and Without Dynamic Obstruction

Debate: Surgery, Septal Ablation or New Medical Therapy for Obstructive HCM - Septal Ablation Is As Good As Surgery and Less Invasive!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content